Differences in gut bacteria can be early indicators for the development of peanut allergies

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has revealed key differences in gut bacteria and their metabolic byproducts in infants that may predict the development of peanut allergies by mid-childhood.

Growth challenges for Novo despite obesity treatment boom

2024 has seen serious issues for Novo Nordisk, headquartered in Bagsvaerd, Denmark. These have included fires at several of its facilities, the withdrawal of one

July 31, 2024

CSPC to launch Paxlovid version in China; SEC charges ex-Pfizer employee with insider trading

Pfizer inked a deal with a Chinese pharma to launch a form of its Covid-19 antiviral Paxlovid in China. The company is working with CSPC

July 1, 2023

Mydecine Innovations Announces Closing of Prospectus Supplement Financing | Psychedelic Invest

Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.